A healthy outlook

Digital Reinvention in healthcare

Download PDF Report

Download PDF report



Executive overview

Authors: Julie Bowser

Connect with author:


, Global Life Sciences Industry Executive,
Sunanda Saxena

Connect with author:


, EA to Jesus Mantas , Managing partner Cognitive Assets & GBS Ventures and Global Head of Strategy & Offerings, GBS,
Anthony Marshall

Connect with author:


, Research Director, IBM Institute for Business Value, IBM Global Business Services,
Heather Fraser

Connect with author:


, Global Lead for Healthcare and Life Sciences

Until recently, healthcare systems and providers focused exclusively on the remediation of specific ailments or systemic challenges. Recent innovations in global healthcare, however, have begun to move the industry away from solely addressing medical issues once they have occurred and toward medical prevention, management and cure. But such initiatives reflect merely a beginning. Current advances in technology will support the ubiquitous orchestration of health and wellness. And these advances will do so affordably, individually and at scale. Digital Reinvention provides the mechanism and overarching vehicle to align healthcare investments and initiatives to realize this vision sooner than many might think. 


Related reports

Disrupting drug discovery

To help accelerate drug discovery, leading organizations and researchers are turning to artificial intelligence (AI) because it can reveal hidden patterns in data.

Driving positive outcomes

Digital technologies are helping life sciences companies secure short-term finances and gain long-term industry benefits.

Loneliness and the aging population

Many diverse stakeholders can now help mitigate the impact of solitude and risks associated with loneliness that are especially detrimental to older adults.

The India cure

Radical reconsideration of healthcare delivery in India is vital to have the resources to service its population with care comparable to other developed nations.